baber/WOPTO huggingface dataset:
Patent NZ-570906-A (NZ)
Title: Rotor turbine having at least two sets of blades where in operation one set of blades open when moving with the wind and the other set of blades is closed when moving against the wind to reduce wind resistance
Inventor: MULHOLLAND EDWARD MARTIN ERIC
IPC: F03D3/02
Filed: 2008-09-01
Abstract: A rotor having a first set of blades and a second set of blades, where each set of blades has a first blade and a second blade arranged on substantially opposite sides of a drive shaft to drive that shaft in a rotary manner, is disclosed. The rotor is formed so that the blades of each set open with respect to one another to harness the wind when moving with the wind and close with respect to one another to reduce resistance to the wind when moving against the wind. The rotor is formed such that when the blades of one set are open the blades of the other set are automatically closed. At least some of the blades have a main face adapted for catching the wind when they are open. Each main face has a substantially inwardly turned distal edge formed to substantially resist air flowing from the main face off the edge when the blade is driven with the wind.
Patent NZ-571374-A (NZ)
Title: Methods for determining proximity between radio frequency devices and controlling switches
Inventor: WILLIS NICHOLAS HEDLEY
IPC: G01S5/02
Filed: 2007-04-02
Abstract: Disclosed is a method for determining the proximity of each other of the radio frequency devices. A receiving radio device is used to periodically measure the Receive Signal Strength Indicator (RSSI) value of a transmitting radio device to provide a series of results. The series of results is analysed using at least one technical indicator. In analysing the series of results, the change in proximity to each other of the radio frequency devices is determined.
Patent NZ-573604-A (NZ)
Title: Coated breakfast cereals that change colour
Inventor: HOITINK ROBERTUS
IPC: A23L7/10
Filed: 2003-11-05
Abstract: Disclosed is a cereal-based product that changes or loses colour upon the addition of an aqueous liquid, the product comprising; a cereal base having the form of spherical balls; at least one outer coating providing a dissolvable colour, which is quickly or easily dissolvable in an aqueous liquid; and an inner coating between the cereal base and the at least one outer coating, the inner coating being a sugar syrup comprising 60-80% sugar and 20-40% water and the weight ratio of cereal base to syrup of the inner coating is in the range 1:1to 3:1. Also disclosed is a process for obtaining a cereal-based product comprising coating a cereal base with an inner coating as described above, drying the coated breakfast cereal to a water content below 10 wt%; and coating the coated breakfast cereal with an outer coating, which is quickly dissolvable in an aqueous liquid. (62) Divided Out of 540374
Patent NZ-576638-A (NZ)
Title: Process for the sulfinylation of a pyrazole derivative
Inventor: SUKOPP MARTIN
IPC: A01N43/56
Filed: 2007-11-05
Abstract: Disclosed is a process for the sulfinylation of a pyrazole derivative, characterized in that 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-1H-pyrazole-3-carbonitrile is reacted with a sulfinylating agent S in the presence of at least one amine acid complex wherein the amine(s) are selected from secondary and/or tertiary amines and the acid(s) are selected from hydrochloric acid, hydrofluoric acid, ptoluenesulfonic acid, benzenesulfonic acid, 4-ethyl benzenesulfonic acid, 4-chlorobenzenesulfonic acid, xylene sulfonic acid, 2,3-dimethylbenzene sulfonic acid, 2,4-dimethylbenzene sulfonic acid, 2,5-dimethylbenzene sulfonic acid, 2,6-dimethylbenzene sulfonic acid, 1-napthalenesulfonic acid, 2- napthalenesulfonic acid, mixtures of two or more of the isomers of dimethylbenzene sulfonic acid, mesitylene sulfonic acid, methanesulfonic acid, camphor sulfonic acid, and trifluoromethylsulfonic acid, , and with the addition of a halogenating agent, wherein S is [CF3S(O)]2O; or CF3S(O)X wherein X means fluoro, chloro, bromo, iodo, a hydroxy group, or an alkaline or alkaline earth metal salt of the hydroxy group; or mixtures thereof, wherein the temperature of the reaction mixture at no time exceeds 39 degrees Celsius. Also disclosed is a method of treating animals against infestation or infection by parasites or protecting growing plants from infestation from insects, acarids or nematodes by applying or ingesting a 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-(trifluoromethylsulfinyl)-pyrazole-3-carbonitrile prepared by the above process.
Patent NZ-586974-A (NZ)
Title: Inhaler with clean air bypass to form cyclone with drug laden air
Inventor: HARMER QUENTIN
IPC: A61M15/00
Filed: 2009-01-14
Abstract: 586973 An inhaler (10) comprising a housing (11) to receive a strip (14) having a plurality of blisters (14a), each blister (14a) having a puncturable lid (14c) and containing a dose of medicament for inhalation by a user, a mouthpiece (13) through which a dose of medicament is inhaled by a user, a cap (12) to cover the mouthpiece (13) and a blister piercing element (16) to pierce the lid (14c) of a blister (14a) is disclosed. The cap (12) is rotatable to drive the strip (14) to sequentially move each blister (14a) into alignment with the blister piercing element (16) and an actuator is operable in response to rotation of the cap (12) to cause the blister piercing element (16) to puncture the lid (14c) of an aligned blister (14a) such that, when a user inhales through the mouthpiece (13), an airflow through the blister (14a) is generated to entrain the dose contained therein and carry it out of the blister (14a) and via the mouthpiece into the user's airway. A link arm is pivotally mounted to the housing and couples the cap to the actuator and pivots in response to rotation of the cap to rotate the actuator, the actuator and the cap being separate components, the mouthpiece being immovably fixed to the housing and the actuator being movable so that it rotates relative to the mouthpiece in response to rotation of the cap to cause the blister piercing element to puncture the lid of an aligned blister.
Patent NZ-587343-A (NZ)
Title: Oxadiazoanthracene compounds for the treatment of diabetes
Inventor: MJALLI ADNAN M M
IPC: A61K31/12
Filed: 2009-03-06
Abstract: Disclosed herein is an oxadiazoanthracene compound for formula (I) wherein rings B and C are not further substituted, R1 is -CO2H, R2 and R4 is hydrogen, and R5 is -O-CH2-(2,3-dicholorophenyl) and the other substituents are as defined within the specification. Processes for their preparation and compositions comprising said compounds are also disclosed. Such compounds are useful in the treatment and/or prevention of disorders and diseases wherein modulation of the human GLP-1 receptor is beneficial.
Patent NZ-587438-A (NZ)
Title: Optimized adhesin fragments comprising mutated afa/dra adhesions and corresponding nanoparticles
Inventor: BLOCK CHRISTOPH
IPC: G01N33/58
Filed: 2008-06-17
Abstract: Disclosed is an adhesin comprising an amino acid sequence selected from the group consisting of the following sequences a. DraE group (SEQ ID No.3) b. DraE/AfaE-III (SEQ ID No.4) c. DraE (SEQ ID No.1) wherein said adhesin has one or more of the following mutations and may be deleted N-terminally by up to 18 amino acids: T7 (N, F, C, S, V, R, A, I, L, V); E17 (S, P, K, G, D, R, N, H, Q); R22 (T, A, S, N, K); D25 (S, G, N, A, T, K, R, H, Q, M); T27 (K, R, L, V, Y, P, N, Q); V28 (W, F); A29 (K, R, S, E, Q, F, G, L, H, P, N, T, W); T31 (G, D, S, N); Q34 (D, G, S, N, L, V, T, A); D37N; A38 (S, T, L); A39 (Q, S, D, M, G, F); 141 (V); Q47 (T, N, C, S, G, A, P); D52 (G, N, S, C, P, Q, Y, H, K, R, T); N84 (D, S, H); R86V; T88 (M, L); T95 (L, M, Y, F, C, W, Q, N, E, S, I, H); F100 (Y, V); V105 (S, A, T, R, M, V, P, N, E, Q, G, K, H); I111 (C, V, H, Y, T, M, F) I114 (V, L, A, C); Y115 (T, W, E, V); V116 (A, S, L); G118 (P, S); provided that when said adhesion contains a T88M and/or a N77K mutation, the adhesin comprises at least one further mutation selected from the above list. Also disclosed is a nanoparticle conjugated to the said adhesion. Further discloses is the use of the said adhesion or nanoparticle in the preparation of a contrast agent for medical use.
Patent NZ-589437-A (NZ)
Title: Immediate release tablet comprising 5-azacytidine and a non-enteric coating applied with an ethanol solvent
Inventor: ETTER JEFFREY B
IPC: A61K9/20
Filed: 2009-05-14
Abstract: Disclosed is a pharmaceutical composition for oral administration comprising a therapeutically effective amount of 5-azacytidine, wherein the composition is a non-enteric-coated immediate-release tablet, which contains a drug core that comprises 5-azacytidine, and further contains a coating of the drug core which is non-enteric, wherein the tablet is obtained by applying the coating to the drug core using solvent comprising ethanol.
Patent NZ-591260-A (NZ)
Title: Method and arrangement in a telecommunication system
Inventor: JOHANSSON NIKLAS
IPC: H04B7/15
Filed: 2009-04-22
Abstract: IP No. A method in a relay node in a wireless communication system and the relay node itself are disclosed. The relay node (1006) is adapted to avoiding or reducing interference between transmissions from a donor evolved Node B (1004) to the relay node and downlink transmissions from the relay node to at least one mobile terminal (1008) connected to the relay node. The relay node comprises an interference avoiding unit adapted to create at least one interruption in the downlink transmissions from the relay node to the at least one mobile terminal and a receiving unit adapted to receive transmissions from the donor evolved Node B during the at least one interruption. The transmissions (1010, 1012) take place in overlapping frequency bands, and the at least one interruption is created by using a Multicast/Broadcast Single Frequency Network-subframe format. A donor evolved Node B (1004) connected to the above described relay node (1006) in a wireless communication system is disclosed. The donor evolved Node B is adapted to avoid or reduce interference between transmissions from the donor evolved Node B to the relay node and downlink transmissions from the relay node to at least one mobile terminal connected to the relay node, The donor evolved Node B comprises a time-shifting unit adapted to shift subframes destined for the relay node one or more OFDM symbol durations in time relative to the relay node downlink subframes and transmitting unit adapted to transmit the time shifted subframes or other subframes to the relay node. The transmissions take place in overlapping frequency bands, and wherein the at least one interruption is created by the relay node using a Multicast/Broadcast Single Frequency Network-subframe format. An arrangement adapted to avoid or reduce interference in a wireless communication system comprising the above described evolved Node B (1004) controlling a donor cell (1002), and the above described relay node (1006) is also disclosed.
Patent NZ-591788-A (NZ)
Title: Layered mask cushion assembly
Inventor: BERTHON-JONES MICHAEL
IPC: A61M16/06
Filed: 2003-11-06
Abstract: A cushion assembly (500) for a mask used for treatment of sleep disordered breathing. The cushion assembly includes: a first layer (540) including a front side adapted for connection to a frame of the mask and a rear side opposite the front side; and a second layer (530) constructed of a foam material and being connected to the rear side of the first layer. The second layer defines a cushion shape and includes a face contacting surface adapted to engage a wearer's face and form a seal between the mask and the wearer's face upon engagement and compress upon application of a force to the cushion assembly. The second layer may include a skin (560).
Patent NZ-593315-A (NZ)
Title: Apparatus and method for combining components for smoking articles
Inventor: TALLIER BERNARD
IPC: A24D1/22
Filed: 2009-12-29
Abstract: 593315 Disclosed is an apparatus and method for combining two or more different components (203, 205, and 207) for the production of smoking articles. At least one of the components (203) cannot be cleanly cut with conventional cutting means, for example because it is prone to splinter or fragment. The method comprises the steps of : feeding a stream of components along a moving delivery path; compacting the stream of components into groups of two or more different components, each group corresponding to a discrete smoking article, wherein the components within a group abut one another and wherein there is a predefined space between a leading group of components and a trailing group of components; wrapping the components in a web of material; and cutting the web of material in each space between groups of components.
Patent NZ-599979-A (NZ)
Title: Flexible forehead support
Inventor: BRAMBILLA ENRICO
IPC: A61M16/00
Filed: 2012-05-14
Abstract: 599979 A respiratory mask has a forehead support attached to a face mask portion so as to have controlled twist of the mask relative to the forehead support.
Patent NZ-613668-A (NZ)
Title: Cellulosic and lignocellulosic structural materials and methods and systems for manufacturing such materials by irradiation
Inventor: MEDOFF MARSHALL
IPC: C08J3/28
Filed: 2009-04-28
Abstract: Disclosed herein is a finished wood product made by a process comprising: irradiating untreated wood with ionizing radiation to produce irradiated wood, the untreated wood having a first molecular weight and a moisture content of less than about 35% by weight, using about 0.25 to about 2.5 MRad of radiation having an energy of about 2.5 MeV to about 7.5 MeV, to increase the molecular weight 5 of a cellulosic component of the irradiated wood to a second, relatively higher molecular weight at least about 10% higher than the first molecular weight; and processing the irradiated wood to a finished product, wherein the ionizing radiation is not electron beam radiation.
Patent NZ-627992-A (NZ)
Title: Compartmentalized method of nucleic acid delivery and compositions and uses thereof
Inventor: CABRERA AQUINO JOSE GUSTAVO
IPC: A61K48/00
Filed: 2013-02-07
Abstract: Disclosed is the use of a composition for manufacture of a medicament for treating a disease or condition treatable by a therapeutic nucleic acid, wherein: - the composition comprises a delivery agent comprising the therapeutic nucleic acid molecule; - the composition is formulated as suitable for injection of the delivery agent comprising the nucleic acid molecule into the parenchyma of a compartmentalised tissue, organ, or portion of a tissue or organ sufficient in size to compartmentalise and to effect administration of the composition; - the delivery agent is a virus or vector that comprises the therapeutic nucleic acid; - the composition contains 1 x 10^3 to 1 x 10^12 viral particles or vectors; - the composition contains a single dose of the virus or vector; - the parenchyma of a compartmentalised tissue, organ or portion thereof does not include connective tissue, blood vessels, nerves or ducts; - the disease or condition treatable by a therapeutic nucleic acid is selected from among a genetic deficiency, a disease or condition ameliorated by an exogenous gene product, and a disease or condition involving aberrant or altered expression of a gene product in its etiology; and - the compartmentalised tissue or organ or portion of a tissue or organ is isolated from the systemic circulation, wherein the organ is clamped whereby the arteries, veins, ducts and/or vessels servicing or traversing the tissue or organ or portion of the tissue or organ are blocked so that blood supply and flow to the tissue or organ or portion thereof is reduced or eliminated.
Patent NZ-630849-A (NZ)
Title: Ligands modified by circular permutation as agonists and antagonists
Inventor: ALVAREZ JUAN
IPC: C12P21/06
Filed: 2013-06-06
Abstract: Disclosed is a fusion polypeptide comprising, a first polypeptide fusion partner linked to a modified ligand corresponding to a native ligand of a target receptor, wherein the modified ligand has been circularly permuted to create a new N-terminus and a new C-terminus as compared to the native ligand, and wherein the new N-terminus or the new C-terminus of the modified ligand is linked to a first polypeptide fusion partner to form a fusion polypeptide wherein the new C-terminus and the new N-terminus of the modified ligand do not disrupt any binding domain of the modified ligand for the target receptor and wherein the modified ligand optionally has increased affinity for the target receptor as compared to the native ligand for the receptor, wherein the modified ligand is circularly permuted IL-2, the fusion partner is IL-2Rα and the target receptor is IL-2Rβγ. Further disclosed is a fusion polypeptide comprising a first polypeptide fusion partner linked to a modified ligand corresponding to a native ligand of a target receptor, wherein the modified ligand has been circularly permuted to create a new N-terminus and a new C-terminus as compared to the native ligand, wherein the new C-terminus and the new N-terminus of the modified ligand do not disrupt any binding domain of the modified ligand for the target receptor, wherein the modified ligand is circularly permuted IL-15, the fusion partner is IL-15Rα and the target receptor is IL-2Rβγ.
Patent NZ-720080-A (NZ)
Title: Assembly for retaining and securing an optical cable and retaining element therefor.
Inventor: ABBIATI FABIO
IPC: H02G15/007
Filed: 2013-11-08
Abstract: Disclosed is an assembly for retaining and securing an optical cable. The assembly seeks to improve retention and securing of optical cables of different diameters without cable ties. The assembly (1) comprises a retaining element (20) and a housing (10). The retaining element (20) comprises a seat (22) configured to receive the optical cable, an insertion port configured to allow side insertion of the optical cable in the seat, at least one elastic portion configured to act on the optical cable received in the seat for retaining the optical cable, and two openings for passage of the optical cable. The seat (22) and the insertion port extend between the two openings. The housing (10) has a mounting surface (11) for removably attaching the retaining element to the housing. The mounting surface (11) is configured to close the insertion port when the retaining element is attached to the mounting surface for securing the optical cable with respect to the housing (10).
Patent NZ-722436-A (NZ)
Title: Synergistic fungicidal mixtures and compositions for fungal control
Inventor: OWEN JOHN W
IPC: A01N43/54
Filed: 2014-12-30
Abstract: The present invention relates to a synergistic fungicidal mixture comprising a fungicidally effective amount of the compound of Formula I: 5-fluoro-4-imino-3-methyl-1-tosyl-3,4-dihydropyrimidin-2-(1H)-one, and at least one (i) fungicidal multi-site inhibitor or (ii) strobilurin fungicide, that provides synergistic control of selected fungi. This invention also relates to synergistic fungal composition containing this mixture.
Patent NZ-723762-A (NZ)
Title: Macrocycles with hetrocyclic p2’ groups as factor xia inhibitors
Inventor: ORWAT MICHAEL J
IPC: C07D471/08
Filed: 2015-01-30
Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
Patent NZ-734320-A (NZ)
Title: Tugboat provided with a carrousel-type towing system
Inventor: MULLER CORNELIS LEVINUS
IPC: B63B35/68
Filed: 2016-02-02
Abstract: The invention relates to a tugboat (1), comprising a single hull (2), a deck (3) and a towing system (4) having a base (5) connected to the deck, the base having a centre point (CP), and a cart (6) that is moveable over the base over 360°, wherein the cart comprises a powered winch (7), wherein two propulsion units (12) are provided, capable of providing thrust over 360° in a horizontal plane, wherein the propulsion units are aligned in the longitudinal direction, wherein the distance between the propulsion units is at least 10% of a length (L) of the tugboat in the longitudinal direction, wherein the tugboat is configured such that during towing the vertical distance between the centre point and the waterline (Hcp) divided by the vertical distance between the centre of thrust of the propulsion units and the waterline (Hp) is 0,3 - 1,5. The problems to be solved are the excess thrust needed and the high likelihood of rolling or capsizing with the current systems. The invention solves this by improving the placement of the propulsion units which improves counterforces.
Patent NZ-753213-A (NZ)
Title: Antibodies and polypeptides directed against cd127
Inventor: MARY CAROLINE
IPC: C07K16/28
Filed: 2017-12-07
Abstract: The invention is in the field of antibodies useful in therapeutic and diagnostics applications targeting CD127, the alpha chain of the IL7 receptor, and provides in particular humanized monoclonal antibodies against CD127, particularly human CD127, therapeutic uses thereof, and diagnostics applications. In particular, the present invention relates to variants of the humanized anti-human CD127 antibody N13B2-h3. The anti-CD127 antibody of the present invention comprises one of four humanized variable light chain sequences are provided (SEQ ID Nos 9-12) whose sequences merely differ in positions 48 and 87, with the heavy chain sequences of the parent antibody N13B2-h3 (SEQ ID No: 7). The antibody of the present invention is expressed in higher yields than the parent antibody.
Patent NZ-753877-A (NZ)
Title: Processing meat batches
Inventor: LINN STEFAN
IPC: G06Q10/08
Filed: 2017-01-10
Abstract: A system for accepting or rejecting a container containing a meat batch comprises a weighting device, a reader and a controller cooperating to effect the acceptance or the rejection of the meat batch. The weighing device to weigh the meat batch and the container to determine batch weight information. The reader is configured to interrogate a machine readable tag attached to the container to retrieve information stored thereon into the controller which is configured to respond to the information retrieved by the reader to access batch information comprising at least information indicative of a fat content of the meat batch and information indicative of the weight of the meat batch when the meat batch is formed, to compare the batch information with a criterion of a recipe related to a target fat content to determine a suitability of the meat batch for inclusion in a mix meeting the recipe, to compare the batch weight information with the information indicative of the weight of the meat batch and the container when the meat batch was formed, to determine a value of their difference, and to generate a control signal dependent the determination to activate an indicator or mechanism for accepting or rejecting the container as appropriate to the determination.